| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2141074 | Lung Cancer | 2013 | 5 Pages |
Abstract
The longer disease control observed in our patients suggests that continuation of EGFR TKI beyond focal progression associated to a locoregional treatment is an efficacious therapeutic strategy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Fabio Conforti, Chiara Catania, Francesca Toffalorio, Matteo Duca, Gianluca Spitaleri, Massimo Barberis, Cristina Noberasco, Angelo Delmonte, Mariacarmela Santarpia, Chiara Lazzari, Tommaso Martino De Pas,